Exagen Inc. (XGN)
NASDAQ: XGN · IEX Real-Time Price · USD
1.780
-0.030 (-1.66%)
At close: Jul 2, 2024, 4:00 PM
1.820
+0.040 (2.25%)
After-hours: Jul 2, 2024, 4:14 PM EDT
Exagen Market Cap
Exagen has a market cap or net worth of $30.92 million as of July 2, 2024. Its market cap has decreased by -40.87% in one year.
Market Cap
30.92M
Enterprise Value
26.70M
1-Year Change
-40.87%
Ranking
Category
Stock Price
$1.78
Market Cap Chart
Since September 19, 2019, Exagen's market cap has decreased from $208.70M to $30.92M, a decrease of -85.18%. That is a compound annual growth rate of -32.90%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 1, 2024 | 31.40M | -7.37% |
Dec 29, 2023 | 33.90M | -13.52% |
Dec 30, 2022 | 39.20M | -79.15% |
Dec 31, 2021 | 188.00M | 12.57% |
Dec 31, 2020 | 167.00M | -47.65% |
Dec 31, 2019 | 319.00M | 52.85% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
ReWalk Robotics | 33.03M |
NKGen Biotech | 32.47M |
Quince Therapeutics | 32.41M |
MiNK Therapeutics | 32.30M |
Cutera | 31.55M |
Vicarious Surgical | 31.22M |
CareCloud | 30.87M |
Palatin Technologies | 30.82M |